Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05085977
Title Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer (Phase 1a) (ADVANCED-1)
Acronym ADVANCED-1
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Protara Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ROU

Facility Status City State Zip Country Details
USC Norris Cancer Center Los Angeles California 90089 United States Details
Mayo Clinic Jacksonville Florida 32224 United States Details
Tulane Medical Center New Orleans Louisiana 70112 United States Details
Chesapeake Urology Research Associates Baltimore Maryland 21204 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
New Jersey Urology Mount Laurel New Jersey 08054 United States Details
Premier Medical Group of the Hudson Valley Poughkeepsie New York 12603 United States Details
University of Rochester, Department of Urology Rochester New York 14642 United States Details
Carolina Urologic Research Center Myrtle Beach South Carolina 29572 United States Details
Urology Associates PC Nashville Tennessee 37209 United States Details
UT Health San Antonio San Antonio Texas 78229 United States Details
PMSI Republican Clinical Hospital "T. Mosneaga," ARENSIA Exploratory Medicine Phase I Unit Chisinau Moldova, Republic of Details
Spitalul Clinic de Nefrologie Carol Davila Bucharest 10731 Romania Details
Arensia Kapitanivka Kapitanivka 08111 Ukraine Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field